RXST logo

RxSight (RXST) Net Income

Annual Net Income

-$48.61 M
+$18.15 M+27.19%

December 31, 2023


Summary


Performance

RXST Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRXSTprofitabilitymetrics:

Quarterly Net Income

-$6.34 M
-$259.00 K-4.26%

September 30, 2024


Summary


Performance

RXST Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRXSTprofitabilitymetrics:

TTM Net Income

-$30.69 M
+$6.08 M+16.53%

September 30, 2024


Summary


Performance

RXST TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRXSTprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

RXST Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+27.2%+30.9%+36.9%
3 y3 years-276.3%+30.9%+36.9%
5 y5 years-138.5%+30.9%+36.9%

RXST Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+27.2%-4.3%+64.0%at high+54.1%
5 y5-year-138.5%+27.2%-120.7%+64.0%-182.3%+54.1%
alltimeall time-138.5%+27.2%-120.7%+64.0%-182.3%+54.1%

RxSight Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$6.34 M(+4.3%)
-$30.69 M(-16.5%)
Jun 2024
-
-$6.08 M(-33.2%)
-$36.77 M(-17.4%)
Mar 2024
-
-$9.10 M(-0.8%)
-$44.50 M(-8.5%)
Dec 2023
-$48.61 M(-27.2%)
-$9.18 M(-26.1%)
-$48.61 M(-11.7%)
Sep 2023
-
-$12.41 M(-10.1%)
-$55.04 M(-7.4%)
Jun 2023
-
-$13.80 M(+4.5%)
-$59.44 M(-4.7%)
Mar 2023
-
-$13.21 M(-15.4%)
-$62.37 M(-6.6%)
Dec 2022
-$66.76 M
-$15.61 M(-7.2%)
-$66.76 M(-0.2%)
Sep 2022
-
-$16.82 M(+0.5%)
-$66.88 M(+6.6%)
Jun 2022
-
-$16.73 M(-4.9%)
-$62.73 M(+5.5%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$17.60 M(+11.8%)
-$59.48 M(+22.2%)
Dec 2021
-$48.69 M(-276.6%)
-$15.73 M(+24.2%)
-$48.69 M(+631.1%)
Sep 2021
-
-$12.67 M(-6.0%)
-$6.66 M(-118.2%)
Jun 2021
-
-$13.48 M(+98.0%)
$36.68 M(-1.6%)
Mar 2021
-
-$6.80 M(-125.9%)
$37.27 M(+35.2%)
Dec 2020
$27.57 M(-78.2%)
$26.30 M(-14.2%)
$27.57 M(+2054.3%)
Sep 2020
-
$30.66 M(-338.0%)
$1.28 M(-104.4%)
Jun 2020
-
-$12.88 M(-21.9%)
-$29.38 M(+78.1%)
Mar 2020
-
-$16.50 M
-$16.50 M
Dec 2019
$126.22 M
-
-

FAQ

  • What is RxSight annual net profit?
  • What is the all time high annual net income for RxSight?
  • What is RxSight annual net income year-on-year change?
  • What is RxSight quarterly net profit?
  • What is the all time high quarterly net income for RxSight?
  • What is RxSight quarterly net income year-on-year change?
  • What is RxSight TTM net profit?
  • What is the all time high TTM net income for RxSight?
  • What is RxSight TTM net income year-on-year change?

What is RxSight annual net profit?

The current annual net income of RXST is -$48.61 M

What is the all time high annual net income for RxSight?

RxSight all-time high annual net profit is $126.22 M

What is RxSight annual net income year-on-year change?

Over the past year, RXST annual net profit has changed by +$18.15 M (+27.19%)

What is RxSight quarterly net profit?

The current quarterly net income of RXST is -$6.34 M

What is the all time high quarterly net income for RxSight?

RxSight all-time high quarterly net profit is $30.66 M

What is RxSight quarterly net income year-on-year change?

Over the past year, RXST quarterly net profit has changed by +$2.84 M (+30.94%)

What is RxSight TTM net profit?

The current TTM net income of RXST is -$30.69 M

What is the all time high TTM net income for RxSight?

RxSight all-time high TTM net profit is $37.27 M

What is RxSight TTM net income year-on-year change?

Over the past year, RXST TTM net profit has changed by +$17.91 M (+36.85%)